Clinical trial
The Effect of 5-Alpha Reductase on Testosterone in Men
NCT00070733 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Unknown status
Key facts
| NCT number | NCT00070733 |
|---|---|
| Title | The Effect of 5-Alpha Reductase on Testosterone in Men |
| Official title | The Role of 5-Alpha Reductase in Mediating Testosterone Actions |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sex Disorders |
| Intervention type | Drug |
| Interventions | testosterone enanthate, duastride |
| Enrollment | 184 |
| Start date | Aug 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Oct 10, 2003 |
| Last update posted | Nov 7, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: